Teva Pharmaceutical Industries Ltd (TEVJF) Change in Working Capital (2025 - 2026)
Teva Pharmaceutical Industries' (TEVJF) quarterly Change in Working Capital came in at -$164.0 million in Q2 2026, up 51.19% YoY from -$108.5 million in Q2 2025, and up 73.42% on a QoQ basis from -$617.0 million in Q1 2026.
Teva Pharmaceutical Industries Ltd (TEVJF) Change in Working Capital (2025 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 2 years of Change in Working Capital data on file, last reported at -$164.0 million in Q2 2026.
- Quarterly Change in Working Capital rose 51.19% year-over-year to -$164.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.8 billion (changed N/A YoY) and the FY2025 annual result came in at -$1.4 billion, down 214.02% from the prior year.
- Change in Working Capital improved to -$164.0 million in Q2 2026, from -$617.0 million in the prior quarter.
- In the past five years, Change in Working Capital ranged from a high of -$164.0 million in Q2 2026 to a low of -$700.0 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -164.00 Mn |
| Jun 30, 2026 | -164.00 Mn |
| Mar 31, 2026 | -617.00 Mn |
| Mar 31, 2026 | -617.00 Mn |
| Jun 30, 2025 | -336.00 Mn |
| Jun 30, 2025 | -336.00 Mn |
| Mar 31, 2025 | -700.00 Mn |
| Mar 31, 2025 | -700.00 Mn |